Sequential biventricular pacing improves regional contractility, longitudinal function and dyssynchrony in patients with heart failure and prolonged QRS.
OBJECTIVE
Biventricular pacing (BiP) is an effective treatment in systolic heart failure (HF) patients with prolonged QRS. However, approximately 35% of the patients receiving BiP are classified as non-responders. The aim of this study is to evaluate the acute effects of VV-optimization on systolic heart function.


METHODS
Twenty-one HF patients aged 72 (46-88) years, QRS 154 (120-190) ms, were studied with echocardiography, Tissue Doppler Imaging (TDI) and 3D-echo the first day after receiving a BiP device. TDI was performed; during simultaneous pacing (LV-lead pacing 4 ms before the RV-lead) and during sequential pacing (LV 20 and 40 ms before RV and RV 20 and 40 ms before LV-lead pacing). Systolic heart function was studied by tissue tracking (TT) for longitudinal function and systolic maximal velocity (SMV) for regional contractility and signs of dyssynchrony assessed by time-delays standard deviation of aortic valve opening to SMV, AVO-SMV/SD and tissue synchronization imaging (TSI).


RESULTS
The TT mean value preoperatively was 4.2 +/- 1.5 and increased at simultaneous pacing to 5.0 +/- 1.2 mm (p < 0.05), and at best VV-interval to 5.4 +/- 1.2 (p < 0.001). Simultaneous pacing achieved better TT distance compared with preoperative in 16 patients (76%). However, it was still higher after VV-optimization in 12 patients 57%. Corresponding figures for SMV were 3.0 +/- 0.7, 3.5 +/- 0.8 (p < 0,01), and 3.6 +/- 0.8 (p < 0.001). Also dyssynchrony improved.


CONCLUSIONS
VV-optimization in the acute phase improves systolic heart function more than simultaneous BiP pacing. Long-term effects should be evaluated in prospective randomized trials.
Edner
Magnus
M
Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Division of Cardiovascular Medicine, Stockholm, Sweden. magnus.edner@ds.se
Ring
Margareta
M
Särev
Tooomas
T
D000368:Aged; D000369:Aged, 80 and over; D002304:Cardiac Pacing, Artificial / Q000379:methods*; D004452:Echocardiography; D005260:Female; D005500:Follow-Up Studies; D054143:Heart Failure, Systolic / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000628:therapy*; D006352:Heart Ventricles; D006801:Humans; D008133:Long QT Syndrome / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D013318:Stroke Volume / Q000502:physiology; D013599:Systole / Q000502:physiology*; D016896:Treatment Outcome
Circulation. 2008 May 20;117(20):2608-16
18458170
Am J Cardiol. 2007 Sep 15;100(6):1002-6
17826387
Eur Heart J. 2009 Oct;30(20):2470-7
19717847
Eur Heart J. 2004 Apr;25(7):571-8
15120054
Am Heart J. 2006 May;151(5):1050-8
16644335
Cardiovasc Ultrasound. 2009 Jan 07;7:1
19128462
Heart. 2003 Jan;89(1):54-60
12482792
J Am Soc Echocardiogr. 2008 Mar;21(3):191-213
18314047
Eur Heart J. 1999 Mar;20(6):447-55
10213348
Circulation. 2007 Apr 24;115(16):2136-44
17420340
N Engl J Med. 2005 Apr 14;352(15):1539-49
15753115
Circulation. 2003 Apr 22;107(15):1985-90
12668512
Eur J Heart Fail. 2001 Jan;3(1):97-103
11163742
J Am Soc Echocardiogr. 1989 Sep-Oct;2(5):358-67
2698218
Circulation. 2004 Mar 2;109(8):978-83
14769701
Circulation. 2002 Oct 15;106(16):2078-84
12379577
J Am Soc Echocardiogr. 2005 Aug;18(8):850-9
16084338
Eur J Heart Fail. 1999 Aug;1(3):229-41
10935669
Eur Heart J. 2001 Feb;22(3):209-17
11161932
N Engl J Med. 2004 May 20;350(21):2140-50
15152059
N Engl J Med. 2002 Jun 13;346(24):1845-53
12063368
Eur Heart J. 2008 Oct;29(19):2388-442
18799522